Researchers explored the potential of Prunus laurocerasus (cherry laurel) and Prunus cerasifera (cherry plum) fruit pits as ...
Personalized genetic interventions like antisense oligonucleotides and genome editing can help children with rare diseases, but it has been difficult for manufacturers to get regulatory approval for ...
Abstract: This letter proposes a new modeling framework for stability assessment in grid-forming virtual synchronous generator. Specifically, the mechanism of self-stability and induced-stability have ...
The Food and Drug Administration Monday unveiled the details of a new policy designed to make it easier and quicker for patients with very rare diseases to get cutting-edge treatments. The new ...
After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
Panelists discuss how the muscarinic pathway of xanomeline/trospium offers a safer, nondopaminergic approach to schizophrenia care. Panelists discuss how xanomeline/trospium chloride introduces a ...
The decision at the COP30 climate talks to create a Belém Action Mechanism (BAM) for Just Transition is a major victory for workers and their trade unions. For the first time ever workers and their ...
In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory pathway that could trigger a seismic shift in how bespoke gene editing therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results